Low Philip S

Endocyte, Inc.

Chief Science Officer, Director

Avg. Two Year Performance

131% Avg. Purchase Return    52% Compound
22% Avg. Sale Return    10% Compound

Holdings: 0 shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount
Buy:0--
Sell:0--

Sentiment

Insider Trading Sentiment: Hold

Company Sentiment

Drug Manufacturers - Major

Drugs

Insider Trading Sentiment:
Insider Trading Sentiment:
Insider Trading Sentiment:

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Sentiment

Company Sentiment

Most Recent Insider Transactions